These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 18835932)
1. Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Xie Z; Zhang J; Wu J; Viollet B; Zou MH Diabetes; 2008 Dec; 57(12):3222-30. PubMed ID: 18835932 [TBL] [Abstract][Full Text] [Related]
2. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH Circ Res; 2010 Apr; 106(6):1117-28. PubMed ID: 20167927 [TBL] [Abstract][Full Text] [Related]
3. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051 [TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Jia F; Wu C; Chen Z; Lu G Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways. Jing M; Cheruvu VK; Ismail-Beigi F Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1071-82. PubMed ID: 18701654 [TBL] [Abstract][Full Text] [Related]
6. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo. Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081 [TBL] [Abstract][Full Text] [Related]
7. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage. Habib SL; Yadav A; Kidane D; Weiss RH; Liang S Cell Cycle; 2016 Nov; 15(22):3048-3059. PubMed ID: 27611085 [TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Shah M; Kola B; Bataveljic A; Arnett TR; Viollet B; Saxon L; Korbonits M; Chenu C Bone; 2010 Aug; 47(2):309-19. PubMed ID: 20399918 [TBL] [Abstract][Full Text] [Related]
9. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Li XN; Song J; Zhang L; LeMaire SA; Hou X; Zhang C; Coselli JS; Chen L; Wang XL; Zhang Y; Shen YH Diabetes; 2009 Oct; 58(10):2246-57. PubMed ID: 19592618 [TBL] [Abstract][Full Text] [Related]
10. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells. Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol via activation of LKB1-AMPK signaling suppresses oxidative stress to prevent endothelial dysfunction in diabetic mice. Hu M; Liu B Clin Exp Hypertens; 2016; 38(4):381-7. PubMed ID: 27149559 [TBL] [Abstract][Full Text] [Related]
12. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388 [TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Chen Z; Peng IC; Sun W; Su MI; Hsu PH; Fu Y; Zhu Y; DeFea K; Pan S; Tsai MD; Shyy JY Circ Res; 2009 Feb; 104(4):496-505. PubMed ID: 19131647 [TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression. Kim JE; Kim YW; Lee IK; Kim JY; Kang YJ; Park SY J Pharmacol Sci; 2008 Mar; 106(3):394-403. PubMed ID: 18360094 [TBL] [Abstract][Full Text] [Related]
15. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells. Dagher Z; Ruderman N; Tornheim K; Ido Y Circ Res; 2001 Jun; 88(12):1276-82. PubMed ID: 11420304 [TBL] [Abstract][Full Text] [Related]
16. In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Wang S; Xu J; Song P; Viollet B; Zou MH Diabetes; 2009 Aug; 58(8):1893-901. PubMed ID: 19528375 [TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hattori Y; Suzuki K; Hattori S; Kasai K Hypertension; 2006 Jun; 47(6):1183-8. PubMed ID: 16636195 [TBL] [Abstract][Full Text] [Related]
18. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes. Gaidhu MP; Perry RL; Noor F; Ceddia RB Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641 [TBL] [Abstract][Full Text] [Related]